143193-46-8 Usage
General Description
5-(4-carboxy-2-nitrophenoxy)isophthalic acid is a chemical compound with the molecular formula C16H9NO8. It is a derivative of isophthalic acid and contains a carboxylic acid group and a nitrophenyl group. 5-(4-CARBOXY-2-NITROPHENOXY)ISOPHTHALIC ACID is commonly used in the synthesis of metal-organic frameworks and coordination polymers, as well as in the production of pharmaceuticals and dyes. It exhibits potential applications in catalysis, gas storage, and drug delivery systems due to its unique structure and functional groups. Additionally, it has been studied for its antimicrobial and anti-inflammatory properties.
Check Digit Verification of cas no
The CAS Registry Mumber 143193-46-8 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,4,3,1,9 and 3 respectively; the second part has 2 digits, 4 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 143193-46:
(8*1)+(7*4)+(6*3)+(5*1)+(4*9)+(3*3)+(2*4)+(1*6)=118
118 % 10 = 8
So 143193-46-8 is a valid CAS Registry Number.
InChI:InChI=1/C15H9NO9/c17-13(18)7-1-2-12(11(6-7)16(23)24)25-10-4-8(14(19)20)3-9(5-10)15(21)22/h1-6H,(H,17,18)(H,19,20)(H,21,22)
143193-46-8Relevant articles and documents
Naaladase inhibitors for treating retinal disorders and glaucoma
-
, (2008/06/13)
The present invention relates to pharmaceutical compositions and methods for treating a retinal disorder or glaucoma using NAALADase inhibitors.
Benzenedicarboxylic acid derivatives
-
, (2008/06/13)
New benzenedicarboxylic acid derivative compounds; pharmaceutical compositions, diagnostic methods, and diagnstic kits that include those compounds; and methods of using those compounds for inhibiting NAALADase enzyme activity, detecting diseases where NAALADase levels are altered, effecting neuronal activity, effecting TGF-β activity, inhibiting angiogenesis, and treating glutamate abnormalities, neutopathy, pain, compulsive disorders, prostate diseases, cancers, and glaucoma.
